 Jeremy Prager
Concepts (436)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trachea | 14 | 2026 | 261 | 3.500 |
Why?
| | Tracheal Stenosis | 7 | 2026 | 39 | 2.410 |
Why?
| | Tonsillectomy | 6 | 2025 | 105 | 2.200 |
Why?
| | Otolaryngology | 7 | 2022 | 108 | 1.810 |
Why?
| | Laryngoscopy | 8 | 2024 | 117 | 1.600 |
Why?
| | Bronchoscopy | 13 | 2026 | 227 | 1.560 |
Why?
| | Respiratory Tract Diseases | 4 | 2019 | 175 | 1.530 |
Why?
| | Larynx | 4 | 2024 | 56 | 1.210 |
Why?
| | Tracheomalacia | 4 | 2022 | 17 | 1.160 |
Why?
| | Correspondence as Topic | 3 | 2012 | 16 | 1.060 |
Why?
| | Deglutition Disorders | 4 | 2023 | 147 | 0.930 |
Why?
| | Laryngostenosis | 3 | 2023 | 54 | 0.920 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2025 | 25 | 0.920 |
Why?
| | Papilloma | 1 | 2025 | 49 | 0.900 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2018 | 106 | 0.890 |
Why?
| | Antiemetics | 1 | 2025 | 49 | 0.880 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2025 | 55 | 0.870 |
Why?
| | Otitis Media | 7 | 2023 | 181 | 0.870 |
Why?
| | Mouth Neoplasms | 1 | 2025 | 90 | 0.850 |
Why?
| | Child | 56 | 2026 | 22633 | 0.850 |
Why?
| | Bronchi | 1 | 2026 | 267 | 0.820 |
Why?
| | Airway Obstruction | 6 | 2021 | 162 | 0.820 |
Why?
| | Tomography, Optical Coherence | 1 | 2026 | 271 | 0.800 |
Why?
| | Papillomavirus Infections | 3 | 2025 | 345 | 0.800 |
Why?
| | Esophagoscopy | 4 | 2020 | 221 | 0.780 |
Why?
| | Efficiency, Organizational | 4 | 2019 | 139 | 0.780 |
Why?
| | Dexamethasone | 1 | 2025 | 372 | 0.770 |
Why?
| | Gastrointestinal Diseases | 3 | 2019 | 216 | 0.750 |
Why?
| | Operating Rooms | 2 | 2015 | 146 | 0.750 |
Why?
| | Tracheostomy | 3 | 2025 | 142 | 0.740 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 3 | 2021 | 37 | 0.710 |
Why?
| | Adenoidectomy | 4 | 2021 | 81 | 0.700 |
Why?
| | Otorhinolaryngologic Diseases | 2 | 2019 | 16 | 0.690 |
Why?
| | Polytetrafluoroethylene | 1 | 2021 | 25 | 0.690 |
Why?
| | Respiratory Sounds | 2 | 2018 | 105 | 0.670 |
Why?
| | Child, Preschool | 34 | 2026 | 11787 | 0.630 |
Why?
| | Abscess | 1 | 2020 | 75 | 0.630 |
Why?
| | Ancillary Services, Hospital | 1 | 2019 | 2 | 0.610 |
Why?
| | Congenital Abnormalities | 2 | 2024 | 104 | 0.610 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 161 | 0.600 |
Why?
| | Hospitals, Pediatric | 6 | 2020 | 556 | 0.590 |
Why?
| | Digestive System Diseases | 1 | 2019 | 27 | 0.590 |
Why?
| | Humans | 88 | 2026 | 144759 | 0.580 |
Why?
| | Helicobacter Infections | 1 | 2018 | 30 | 0.570 |
Why?
| | Internship and Residency | 4 | 2020 | 1257 | 0.570 |
Why?
| | Helicobacter pylori | 1 | 2018 | 45 | 0.570 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 176 | 0.560 |
Why?
| | Patient Care Team | 3 | 2019 | 689 | 0.560 |
Why?
| | Infant | 25 | 2026 | 10034 | 0.550 |
Why?
| | Tracheal Neoplasms | 1 | 2018 | 12 | 0.540 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 330 | 0.540 |
Why?
| | Retrospective Studies | 26 | 2026 | 17066 | 0.530 |
Why?
| | Intubation, Intratracheal | 3 | 2015 | 320 | 0.530 |
Why?
| | Paraganglioma | 1 | 2018 | 53 | 0.510 |
Why?
| | Male | 49 | 2026 | 72315 | 0.500 |
Why?
| | Quality Improvement | 3 | 2016 | 1289 | 0.470 |
Why?
| | Gastroesophageal Reflux | 4 | 2023 | 236 | 0.470 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 299 | 0.460 |
Why?
| | Tracheoesophageal Fistula | 3 | 2022 | 38 | 0.450 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 34 | 0.450 |
Why?
| | Spinal Fractures | 1 | 2015 | 73 | 0.440 |
Why?
| | Patient Satisfaction | 2 | 2019 | 704 | 0.440 |
Why?
| | Gastroenterology | 3 | 2023 | 189 | 0.430 |
Why?
| | Phenol | 1 | 2014 | 18 | 0.430 |
Why?
| | Female | 45 | 2026 | 78271 | 0.430 |
Why?
| | Clinical Competence | 4 | 2020 | 1244 | 0.420 |
Why?
| | Drug Labeling | 1 | 2014 | 37 | 0.420 |
Why?
| | Burns, Chemical | 1 | 2014 | 32 | 0.420 |
Why?
| | Anti-Infective Agents, Local | 1 | 2014 | 40 | 0.420 |
Why?
| | Delphi Technique | 8 | 2024 | 329 | 0.410 |
Why?
| | Medical Audit | 1 | 2014 | 77 | 0.400 |
Why?
| | Chromosome Disorders | 1 | 2013 | 45 | 0.400 |
Why?
| | Postoperative Complications | 6 | 2022 | 2919 | 0.390 |
Why?
| | Thyroid Neoplasms | 3 | 2023 | 345 | 0.380 |
Why?
| | Career Choice | 2 | 2011 | 237 | 0.370 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 316 | 0.360 |
Why?
| | Abnormalities, Multiple | 1 | 2013 | 197 | 0.360 |
Why?
| | Adolescent | 26 | 2026 | 22428 | 0.350 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 97 | 0.350 |
Why?
| | Student Dropouts | 1 | 2011 | 8 | 0.350 |
Why?
| | Writing | 1 | 2012 | 100 | 0.340 |
Why?
| | Job Description | 1 | 2010 | 12 | 0.330 |
Why?
| | Deafness | 1 | 2012 | 78 | 0.330 |
Why?
| | Pharyngeal Diseases | 1 | 2010 | 16 | 0.330 |
Why?
| | Cochlear Implantation | 1 | 2012 | 82 | 0.330 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2024 | 237 | 0.330 |
Why?
| | Education, Medical, Continuing | 1 | 2011 | 132 | 0.330 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2012 | 192 | 0.330 |
Why?
| | Pediatrics | 4 | 2019 | 1114 | 0.320 |
Why?
| | Bronchiectasis | 3 | 2020 | 112 | 0.320 |
Why?
| | Pulmonary Embolism | 1 | 2013 | 244 | 0.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.320 |
Why?
| | School Admission Criteria | 1 | 2010 | 34 | 0.320 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 676 | 0.300 |
Why?
| | Tracheotomy | 4 | 2019 | 23 | 0.300 |
Why?
| | Personnel Selection | 1 | 2010 | 93 | 0.300 |
Why?
| | Palatine Tonsil | 2 | 2021 | 55 | 0.280 |
Why?
| | Thoracoscopy | 2 | 2019 | 62 | 0.280 |
Why?
| | Microbiota | 5 | 2023 | 781 | 0.280 |
Why?
| | Esophageal Atresia | 2 | 2020 | 30 | 0.270 |
Why?
| | Infant, Newborn | 8 | 2023 | 6429 | 0.270 |
Why?
| | Hearing Loss, Conductive | 1 | 2007 | 24 | 0.270 |
Why?
| | Faculty, Medical | 1 | 2010 | 302 | 0.260 |
Why?
| | Anesthesia | 2 | 2023 | 258 | 0.260 |
Why?
| | Craniosynostoses | 1 | 2007 | 68 | 0.250 |
Why?
| | Program Development | 2 | 2019 | 370 | 0.240 |
Why?
| | Ear, Middle | 5 | 2023 | 85 | 0.240 |
Why?
| | Deglutition | 2 | 2024 | 72 | 0.240 |
Why?
| | Mandibular Fractures | 1 | 2026 | 14 | 0.240 |
Why?
| | Treatment Outcome | 9 | 2024 | 11679 | 0.240 |
Why?
| | Surgeons | 2 | 2020 | 339 | 0.230 |
Why?
| | Down Syndrome | 2 | 2023 | 534 | 0.220 |
Why?
| | Biopsy | 3 | 2019 | 1075 | 0.220 |
Why?
| | Tracheobronchomalacia | 2 | 2022 | 15 | 0.220 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1560 | 0.220 |
Why?
| | Administration, Intravenous | 1 | 2025 | 170 | 0.220 |
Why?
| | Papillomaviridae | 1 | 2025 | 115 | 0.210 |
Why?
| | Nasal Septal Perforation | 1 | 2024 | 5 | 0.210 |
Why?
| | Respiratory Tract Infections | 3 | 2021 | 397 | 0.210 |
Why?
| | Fascia | 1 | 2024 | 17 | 0.210 |
Why?
| | Sutures | 2 | 2021 | 64 | 0.210 |
Why?
| | Consensus | 4 | 2024 | 488 | 0.200 |
Why?
| | Administration, Oral | 2 | 2025 | 847 | 0.200 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 5 | 0.200 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 5 | 0.200 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 14 | 0.200 |
Why?
| | Croup | 1 | 2023 | 19 | 0.190 |
Why?
| | Membrane Proteins | 2 | 2021 | 1166 | 0.190 |
Why?
| | Prospective Studies | 5 | 2025 | 7990 | 0.190 |
Why?
| | Vocal Cord Dysfunction | 1 | 2022 | 9 | 0.190 |
Why?
| | Hypoparathyroidism | 1 | 2022 | 7 | 0.180 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2022 | 16 | 0.180 |
Why?
| | Graves Disease | 1 | 2022 | 30 | 0.180 |
Why?
| | Colorado | 5 | 2020 | 4564 | 0.180 |
Why?
| | Laryngoscopes | 1 | 2022 | 45 | 0.180 |
Why?
| | Constriction, Pathologic | 4 | 2023 | 248 | 0.170 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.170 |
Why?
| | Nasopharynx | 1 | 2022 | 73 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Double-Blind Method | 2 | 2025 | 2029 | 0.170 |
Why?
| | Medicine | 1 | 2023 | 125 | 0.170 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 12 | 0.170 |
Why?
| | Nasal Obstruction | 1 | 2021 | 26 | 0.170 |
Why?
| | Job Satisfaction | 1 | 2023 | 240 | 0.160 |
Why?
| | Plasminogen | 1 | 2020 | 27 | 0.160 |
Why?
| | Nasal Septum | 1 | 2020 | 30 | 0.160 |
Why?
| | Hematoma | 1 | 2020 | 59 | 0.160 |
Why?
| | Mucolipidoses | 1 | 2020 | 9 | 0.160 |
Why?
| | Bevacizumab | 1 | 2021 | 167 | 0.160 |
Why?
| | Follow-Up Studies | 7 | 2019 | 5408 | 0.150 |
Why?
| | Bone Marrow Transplantation | 4 | 1997 | 294 | 0.150 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 7 | 0.150 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 14 | 0.150 |
Why?
| | United States | 8 | 2025 | 15966 | 0.150 |
Why?
| | Tracheal Diseases | 1 | 2019 | 15 | 0.150 |
Why?
| | Cartilage | 1 | 2021 | 198 | 0.150 |
Why?
| | Arytenoid Cartilage | 1 | 2019 | 6 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 23 | 0.150 |
Why?
| | Angiogenesis Inhibitors | 1 | 2021 | 237 | 0.150 |
Why?
| | Laryngomalacia | 1 | 2018 | 5 | 0.140 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 51 | 0.140 |
Why?
| | Laryngoplasty | 1 | 2018 | 5 | 0.140 |
Why?
| | Models, Organizational | 1 | 2019 | 144 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 340 | 0.140 |
Why?
| | Airway Extubation | 1 | 2019 | 60 | 0.140 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 79 | 0.140 |
Why?
| | Young Adult | 9 | 2024 | 14105 | 0.140 |
Why?
| | Respiratory System | 1 | 2019 | 149 | 0.140 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 197 | 0.140 |
Why?
| | Respiration Disorders | 1 | 2018 | 77 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 251 | 0.140 |
Why?
| | Registries | 2 | 2024 | 2385 | 0.140 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.130 |
Why?
| | Child Behavior | 1 | 2020 | 236 | 0.130 |
Why?
| | Proton Pump Inhibitors | 1 | 2018 | 109 | 0.130 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2925 | 0.130 |
Why?
| | Carcinoma, Medullary | 1 | 2017 | 16 | 0.130 |
Why?
| | Midazolam | 2 | 2015 | 72 | 0.130 |
Why?
| | Virtual Reality | 1 | 2019 | 77 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 410 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 627 | 0.120 |
Why?
| | Reoperation | 2 | 2018 | 630 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 634 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2023 | 484 | 0.120 |
Why?
| | Gastrostomy | 1 | 2018 | 130 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 824 | 0.120 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 32 | 0.110 |
Why?
| | Androstanols | 1 | 2015 | 30 | 0.110 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 558 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2363 | 0.110 |
Why?
| | Anesthetics, Intravenous | 1 | 2015 | 69 | 0.110 |
Why?
| | Clinical Audit | 1 | 2015 | 14 | 0.110 |
Why?
| | Time and Motion Studies | 1 | 2015 | 28 | 0.110 |
Why?
| | Mouth | 1 | 2015 | 88 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Esophagus | 3 | 2024 | 261 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 6048 | 0.110 |
Why?
| | DNA, Recombinant | 1 | 2014 | 48 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3409 | 0.110 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 32 | 0.110 |
Why?
| | Program Evaluation | 1 | 2019 | 948 | 0.110 |
Why?
| | Fentanyl | 1 | 2015 | 127 | 0.100 |
Why?
| | Prognosis | 3 | 2018 | 4282 | 0.100 |
Why?
| | Administration, Intranasal | 1 | 2014 | 93 | 0.100 |
Why?
| | Survival Rate | 2 | 2018 | 2089 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 3 | 2020 | 2730 | 0.100 |
Why?
| | Pedigree | 3 | 2020 | 514 | 0.100 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 8 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2019 | 691 | 0.100 |
Why?
| | Iatrogenic Disease | 1 | 2014 | 76 | 0.100 |
Why?
| | Anesthetics, Local | 1 | 2014 | 100 | 0.100 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 134 | 0.100 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 78 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 983 | 0.100 |
Why?
| | Chromosome Deletion | 1 | 2013 | 124 | 0.100 |
Why?
| | Appointments and Schedules | 1 | 2014 | 97 | 0.100 |
Why?
| | Hospitalization | 2 | 2026 | 2433 | 0.100 |
Why?
| | Radiography | 1 | 2015 | 844 | 0.100 |
Why?
| | Pharyngitis | 1 | 2013 | 25 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2018 | 600 | 0.100 |
Why?
| | Tetanus Antitoxin | 1 | 1992 | 2 | 0.090 |
Why?
| | Rhinitis | 1 | 2014 | 171 | 0.090 |
Why?
| | Neuralgia | 1 | 2014 | 144 | 0.090 |
Why?
| | Graft Rejection | 1 | 2016 | 540 | 0.090 |
Why?
| | Tetanus Toxoid | 1 | 1992 | 34 | 0.090 |
Why?
| | Antibodies | 1 | 2014 | 401 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2013 | 307 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1782 | 0.090 |
Why?
| | Immunization, Secondary | 1 | 1992 | 91 | 0.090 |
Why?
| | Sinusitis | 1 | 2014 | 228 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2015 | 547 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 557 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 4089 | 0.090 |
Why?
| | Asthma | 1 | 2023 | 1767 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1694 | 0.090 |
Why?
| | Patient Safety | 1 | 2015 | 347 | 0.080 |
Why?
| | Cytosine | 1 | 2011 | 51 | 0.080 |
Why?
| | Off-Label Use | 1 | 2011 | 49 | 0.080 |
Why?
| | Ear Ossicles | 1 | 2010 | 11 | 0.080 |
Why?
| | Time Factors | 3 | 2019 | 7173 | 0.080 |
Why?
| | Organophosphonates | 1 | 2011 | 97 | 0.080 |
Why?
| | Patient Readmission | 1 | 2016 | 758 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 140 | 0.080 |
Why?
| | Airway Management | 1 | 2011 | 79 | 0.080 |
Why?
| | Disclosure | 1 | 2010 | 85 | 0.080 |
Why?
| | Professional Competence | 1 | 2010 | 98 | 0.080 |
Why?
| | Teratoma | 1 | 2011 | 120 | 0.080 |
Why?
| | Thyroidectomy | 2 | 2022 | 91 | 0.070 |
Why?
| | Referral and Consultation | 1 | 2015 | 851 | 0.070 |
Why?
| | Preanesthetic Medication | 1 | 1988 | 6 | 0.070 |
Why?
| | Patient Selection | 1 | 2012 | 719 | 0.070 |
Why?
| | Communication | 1 | 2015 | 965 | 0.070 |
Why?
| | Anesthesia, Local | 1 | 1988 | 25 | 0.070 |
Why?
| | Middle Ear Ventilation | 1 | 2007 | 18 | 0.070 |
Why?
| | Electronic Health Records | 1 | 2016 | 1173 | 0.070 |
Why?
| | Audiometry | 1 | 2007 | 35 | 0.070 |
Why?
| | Mice | 6 | 2022 | 18339 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3863 | 0.070 |
Why?
| | Prevalence | 2 | 2020 | 2834 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2014 | 2832 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2011 | 767 | 0.060 |
Why?
| | Risk Factors | 3 | 2019 | 10779 | 0.060 |
Why?
| | Hematologic Diseases | 1 | 1986 | 66 | 0.060 |
Why?
| | Catheters, Indwelling | 1 | 1986 | 96 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 558 | 0.060 |
Why?
| | Multiple Trauma | 1 | 2026 | 116 | 0.050 |
Why?
| | Pilot Projects | 1 | 2010 | 1886 | 0.050 |
Why?
| | Temporal Muscle | 1 | 2024 | 3 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1356 | 0.050 |
Why?
| | Cadaver | 2 | 2019 | 304 | 0.050 |
Why?
| | Absorbable Implants | 1 | 2024 | 37 | 0.050 |
Why?
| | Polyesters | 1 | 2024 | 80 | 0.050 |
Why?
| | Transplantation, Homologous | 4 | 2011 | 415 | 0.050 |
Why?
| | Observer Variation | 1 | 2024 | 355 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 212 | 0.050 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2023 | 35 | 0.050 |
Why?
| | Hyperplasia | 1 | 2023 | 174 | 0.050 |
Why?
| | Accidental Falls | 1 | 2026 | 222 | 0.050 |
Why?
| | Animals | 6 | 2022 | 38058 | 0.050 |
Why?
| | Breathing Exercises | 1 | 2022 | 21 | 0.050 |
Why?
| | Vocal Cords | 1 | 2022 | 26 | 0.050 |
Why?
| | Cough | 1 | 2023 | 124 | 0.050 |
Why?
| | Biofeedback, Psychology | 1 | 2022 | 35 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 67 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 433 | 0.040 |
Why?
| | Societies, Medical | 1 | 2025 | 887 | 0.040 |
Why?
| | Esophagoscopes | 1 | 2020 | 4 | 0.040 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 1992 | 682 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2021 | 62 | 0.040 |
Why?
| | Perioperative Period | 1 | 2020 | 71 | 0.040 |
Why?
| | Internationality | 1 | 2021 | 156 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 478 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 2194 | 0.040 |
Why?
| | Laryngeal Mucosa | 1 | 2019 | 5 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 52 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2020 | 107 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 78 | 0.040 |
Why?
| | Finland | 1 | 2019 | 79 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2019 | 312 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5992 | 0.040 |
Why?
| | Patient Discharge | 1 | 2025 | 983 | 0.040 |
Why?
| | Athletic Injuries | 1 | 2026 | 569 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 22 | 0.040 |
Why?
| | Lung | 2 | 2023 | 4109 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 652 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 249 | 0.040 |
Why?
| | Nerve Fibers | 1 | 2019 | 104 | 0.040 |
Why?
| | California | 1 | 2020 | 475 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2020 | 282 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 181 | 0.030 |
Why?
| | Electric Impedance | 1 | 2018 | 111 | 0.030 |
Why?
| | Device Removal | 1 | 2019 | 143 | 0.030 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 26 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 488 | 0.030 |
Why?
| | Emotions | 1 | 2023 | 578 | 0.030 |
Why?
| | Infant, Premature | 1 | 2022 | 611 | 0.030 |
Why?
| | Exome | 1 | 2018 | 227 | 0.030 |
Why?
| | Chickenpox Vaccine | 1 | 1997 | 75 | 0.030 |
Why?
| | Anesthetics | 1 | 2018 | 99 | 0.030 |
Why?
| | Transplantation, Autologous | 3 | 1992 | 290 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2017 | 126 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 442 | 0.030 |
Why?
| | Caregivers | 1 | 2025 | 1049 | 0.030 |
Why?
| | Taste Buds | 1 | 2019 | 212 | 0.030 |
Why?
| | Survival Analysis | 2 | 2017 | 1382 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 265 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2021 | 544 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1135 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 231 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 255 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1658 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 508 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 769 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 3333 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 396 | 0.030 |
Why?
| | Tongue | 1 | 2015 | 76 | 0.030 |
Why?
| | Hypertrophy | 1 | 2015 | 127 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 834 | 0.030 |
Why?
| | Adolescent Behavior | 1 | 2020 | 501 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1716 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1095 | 0.030 |
Why?
| | Long-Term Care | 1 | 2015 | 117 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 645 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 1045 | 0.030 |
Why?
| | Benzofurans | 1 | 2014 | 26 | 0.030 |
Why?
| | Pain Threshold | 1 | 2014 | 73 | 0.030 |
Why?
| | TRPV Cation Channels | 1 | 2014 | 43 | 0.030 |
Why?
| | Neural Conduction | 1 | 2014 | 92 | 0.030 |
Why?
| | Adult | 6 | 2023 | 40449 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 675 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2014 | 88 | 0.030 |
Why?
| | Sensory Receptor Cells | 1 | 2014 | 101 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2014 | 131 | 0.020 |
Why?
| | Thoracotomy | 1 | 2013 | 83 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1462 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2014 | 451 | 0.020 |
Why?
| | Fetal Therapies | 1 | 2013 | 47 | 0.020 |
Why?
| | Quinolines | 1 | 2014 | 193 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2882 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2145 | 0.020 |
Why?
| | Tetanus | 1 | 1992 | 26 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2947 | 0.020 |
Why?
| | Early Detection of Cancer | 1 | 2017 | 463 | 0.020 |
Why?
| | Anemia, Aplastic | 1 | 1992 | 42 | 0.020 |
Why?
| | Pain Measurement | 1 | 2014 | 552 | 0.020 |
Why?
| | Endoscopy | 1 | 2014 | 316 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2013 | 294 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5960 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2011 | 36 | 0.020 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 300 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 824 | 0.020 |
Why?
| | Malleus | 1 | 2010 | 1 | 0.020 |
Why?
| | Incus | 1 | 2010 | 6 | 0.020 |
Why?
| | Neoplasms | 1 | 1986 | 2875 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2879 | 0.020 |
Why?
| | Stapes | 1 | 2010 | 25 | 0.020 |
Why?
| | Temporal Bone | 1 | 2010 | 45 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 1992 | 264 | 0.020 |
Why?
| | Aerosols | 1 | 2011 | 186 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2608 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2878 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 574 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2182 | 0.020 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 293 | 0.020 |
Why?
| | Graft Survival | 1 | 2011 | 526 | 0.020 |
Why?
| | Flunitrazepam | 1 | 1988 | 3 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1047 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1813 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1539 | 0.020 |
Why?
| | Random Allocation | 1 | 1988 | 363 | 0.020 |
Why?
| | Morphine | 1 | 1988 | 168 | 0.020 |
Why?
| | Stents | 1 | 2011 | 556 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2010 | 583 | 0.010 |
Why?
| | Ultrasonography | 1 | 2010 | 770 | 0.010 |
Why?
| | Logistic Models | 1 | 2011 | 2117 | 0.010 |
Why?
| | Rats | 1 | 2014 | 5597 | 0.010 |
Why?
| | Signal Transduction | 1 | 2019 | 5226 | 0.010 |
Why?
| | Heart Atria | 1 | 1986 | 144 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2014 | 1907 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5868 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4557 | 0.010 |
Why?
| | Middle Aged | 4 | 2019 | 35875 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 1988 | 1053 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1991 | 1953 | 0.010 |
Why?
| | Pancreatic Function Tests | 1 | 1981 | 3 | 0.010 |
Why?
| | Exocrine Pancreatic Insufficiency | 1 | 1981 | 24 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 7190 | 0.010 |
Why?
| | Somatostatin | 1 | 1980 | 51 | 0.010 |
Why?
| | Dietary Fats | 1 | 1980 | 314 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 1997 | 79 | 0.010 |
Why?
| | Triglycerides | 1 | 1980 | 520 | 0.010 |
Why?
| | Chickenpox | 1 | 1997 | 81 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1997 | 379 | 0.010 |
Why?
| | Herpes Zoster | 1 | 1997 | 315 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 1997 | 672 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1997 | 893 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 2027 | 0.010 |
Why?
| | Bone Marrow Purging | 1 | 1991 | 3 | 0.010 |
Why?
| | Daunorubicin | 1 | 1991 | 25 | 0.010 |
Why?
| | Thioguanine | 1 | 1991 | 18 | 0.010 |
Why?
| | Cytarabine | 1 | 1991 | 66 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1992 | 316 | 0.010 |
Why?
| | Remission Induction | 1 | 1992 | 307 | 0.010 |
Why?
| | Vaccination | 1 | 1997 | 1423 | 0.000 |
Why?
| | Combined Modality Therapy | 1 | 1991 | 1266 | 0.000 |
Why?
| | Aged | 1 | 1988 | 25913 | 0.000 |
Why?
| | Fluoresceins | 1 | 1981 | 48 | 0.000 |
Why?
| | Lipase | 1 | 1980 | 75 | 0.000 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1980 | 158 | 0.000 |
Why?
| | Cholesterol | 1 | 1980 | 406 | 0.000 |
Why?
| | Blood Glucose | 1 | 1980 | 2327 | 0.000 |
Why?
| | Insulin | 1 | 1980 | 2507 | 0.000 |
Why?
|
|
Prager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|